Technical Analysis for NUVA - NuVasive, Inc.

Grade Last Price % Change Price Change
grade B 62.23 0.99% 0.61
NUVA closed up 0.99 percent on Tuesday, May 21, 2019, on 41 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NUVA trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
20 DMA Support Bullish 0.99%
180 Bullish Setup Bullish Swing Setup 0.99%
Inside Day Range Contraction 2.05%
20 DMA Support Bullish 0.42%
20 DMA Support Bullish 2.88%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.88%
Multiple of Ten Bullish Other 2.88%
MACD Bearish Signal Line Cross Bearish 2.71%

Older signals for NUVA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine. The company's products focus on applications for spine fusion surgery. It offers products for the thoracolumbar spine and the cervical spine primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company's principal products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines three categories of product offerings, including NVM5 and NVJJB, its proprietary software-driven nerve detection and avoidance systems, and intra-operative monitoring support services for insight into the nervous system during spine and other surgeries; MaXcess, an integrated split-blade retractor system; and various specialized implants. The company's biologic products include allograft, a donated human tissue; FormaGraft, a collagen synthetic product; Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells; and AttraX, a synthetic bone graft material. It also offers solutions for cervical fusion surgery, including allograft and CoRoent implants, as well as cervical plating and posterior fixation products. In addition, the company's products comprise PCM device, a motion preserving total disc replacement device; and XL TDR, a mechanical total disc replacement solution. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Medicine Surgery Stem Cells Neurosurgery Surgeries Transplantation Medicine Biologic Products Spinal Fusion Allotransplantation Bone Grafting Neurosurgical Procedures Intervertebral Disc Arthroplasty
Is NUVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 72.41
52 Week Low 43.51
Average Volume 493,090
200-Day Moving Average 59.5348
50-Day Moving Average 58.2246
20-Day Moving Average 61.389
10-Day Moving Average 61.484
Average True Range 1.7897
ADX 28.28
+DI 24.162
-DI 13.9446
Chandelier Exit (Long, 3 ATRs ) 60.2709
Chandelier Exit (Short, 3 ATRs ) 58.0591
Upper Bollinger Band 64.3259
Lower Bollinger Band 58.4521
Percent B (%b) 0.64
BandWidth 9.568164
MACD Line 1.0139
MACD Signal Line 1.1834
MACD Histogram -0.1695
Fundamentals Value
Market Cap 3.16 Billion
Num Shares 50.8 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 98.78
Price-to-Sales 2.91
Price-to-Book 4.32
PEG Ratio 2.15
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 63.57
Resistance 3 (R3) 63.58 63.15 63.34
Resistance 2 (R2) 63.15 62.81 63.14 63.27
Resistance 1 (R1) 62.69 62.60 62.92 62.68 63.19
Pivot Point 62.26 62.26 62.38 62.25 62.26
Support 1 (S1) 61.80 61.92 62.03 61.79 61.27
Support 2 (S2) 61.37 61.71 61.36 61.19
Support 3 (S3) 60.91 61.37 61.12
Support 4 (S4) 60.90